Navigation Links
Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session
Date:4/27/2011

BURLINGTON, Mass., April 28, 2011 /PRNewswire/ -- Rhythmia Medical Inc., announced today that key results from its ongoing pre-clinical and clinical studies will be presented at the 2011 Annual Scientific Session of the Heart Rhythm Society in San Francisco, CA. The results will highlight the performance of Rhythmia Medical's mapping system, a technological breakthrough that can significantly improve cardiac ablation procedures by generating high resolution electroanatomical maps faster, simpler and more accurately.

The following presentations are planned:


  • "New System for Rapid, High-Resolution Automated Mapping in Patients with Macroreentrant Atrial Tachycardia/Flutter"
    Dr. Hiroshi Nakagawa, Director of the Clinical Catheter Ablation Program and Translational Electrophysiology at the University of Oklahoma , will present the initial results from the first in man clinical trial using the system for mapping macroreentrant atrial tachycardia and atrial flutter in the session "New Technologies Facilitating Successful Catheter Ablation" on Thursday, May 5, 1:30 - 3:00 p.m. in Moscone West room 2002.
    Dr. Nakagawa will present results from initial investigational studies performed with the cooperation of Professor Josef Kautzner and his team at the Institute for Clinical and Experimental Medicine (IKEM) in Prague.  The study included patients with Atrial Fibrillation, Atrial Tachycardia and Atrial Flutter.


  • "New System for Rapid, High-Resolution Automated Electroanatomical Mapping: Evaluation in a Canine Atrial Incision Model"
    Dr. Hiroshi Nakagawa will present the poster for this pre-clinical study in canines demonstrating the potential of the system to rapidly identify areas of conduction block in the right atrium after linear lesions are created surgically and by ablation. This poster session will be featured on Thursday, May 5, 9:00 AM -12:00 PM. The presentation will show the resolution and performance of the Rhythmia system in this complex experimental model.Cardiac arrhythmia affects more than 7.5 million people in the United States and Europe, and is a life- threatening condition that can lead to stroke or heart failure. Catheter ablation procedures, currently performed at a rate of over 500,000 per year, represent a $2 billion market with one of the fastest growth rates in medical devices.

    The new research provides new insight into the capability of the Rhythmia Medical's mapping system to support catheter ablation procedures by providing a highly accurate electroanatomical map within minutes. "Mapping accuracy is critically important to make sure we can correctly identify the optimal ablation target to minimize unnecessary ablation and avoid repeat procedures. The ability to quickly generate such high resolution maps with minimal operator involvement during mapping will enhance the way Electrophysiologists perform catheter ablation in the future," said Dr. Warren M. (Sonny) Jackman of the University of Oklahoma who participated in the studies.

    Rhythmia Medical's mapping system is an investigational device and is not available for sale in the United States.

    About Rhythmia MedicalFounded in 2004, Rhythmia Medical, Inc. is developing a next generation Mapping, Visualization and Navigation system for the treatment of cardiac arrhythmias. The company recently began human clinical testing outside the US and is working with several of the leading clinicians in this field around the world. The Burlington, Massachusetts-based venture-backed company has raised $19 million of financing. Additional information can be found at www.rhythmia.com


    '/>"/>

  • SOURCE Rhythmia Medical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
    2. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
    3. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
    4. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
    5. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2011
    6. Southern Home Medical Equipment Reports First Quarter 2011 Results in Revenues and Profits
    7. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
    8. Dehaier Medical to Report First Quarter 2011 Financial Results on May 4
    9. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
    10. LATEST Medical Introduces New Kind of Patient Information Web Site - LATESTBreastCancer.com
    11. Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/12/2016)... 12, 2016  Clinical Affairs leaders at pharmaceutical organizations are looking ... of the world. While some companies have conducted a significant number ... activity in countries such as India and ... and India are now requiring local ... countries. --> China and ...
    (Date:2/12/2016)... , Feb. 12, 2016   National Community Pharmacists ... RPh, MBA issued the following statement today in response ... by the Centers for Medicare & Medicaid Services ... NCPA, beneficiary advocates and others: patient advocacy ... are still reviewing the full CMS analysis. Our initial ...
    (Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
    Breaking Medicine Technology:
    (Date:2/13/2016)... ... February 13, 2016 , ... The National ... the leading national organization representing the growing community of recovering individuals (now over ... include Family Recovery in policies addressing addiction. , Although many of the ...
    (Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy ... of reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those ... the high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams ...
    (Date:2/13/2016)... ... February 13, 2016 , ... With FCPX Overlay Embers from Pixel Film Studios ... Cut Pro X. Each user can select from up to 40 effect overlays. With ... focus offset, hue, saturation, value, contrast, glow, and more all within a click of ...
    (Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises ... businesses. , The increasingly modern world of instantaneous consumption proves very convenient for ... sources such as oil and coal, which pollutes our air, water, and soil. It ...
    (Date:2/13/2016)... ... 2016 , ... In its newly released Infusion Therapy Standards ... be used to ensure patient safety when placing an IV catheter. A key ... use of vein visualization technology in patients with difficult venous access or after ...
    Breaking Medicine News(10 mins):